BeOne Medicines (ONC) EPS (Basic) Growth (1y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -13.31% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -100.00% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -79.34% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 61.11% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -7.78% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | -3,856.63% |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 1,207.14% |
| 10 | BeOne Medicines | - | - | 1.35 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 136.36% |
| Sep 30, 2025 | 200.00% |
| Jun 30, 2025 | 177.78% |
| Dec 31, 2024 | 59.26% |
| Sep 30, 2024 | -156.25% |
| Jun 30, 2024 | 67.86% |
| Mar 31, 2024 | 26.92% |
| Dec 31, 2023 | 18.18% |
| Sep 30, 2023 | 139.02% |
| Jun 30, 2023 | 33.33% |
| Mar 31, 2023 | 21.21% |
| Dec 31, 2022 | 32.65% |
| Sep 30, 2022 | -13.89% |
| Jun 30, 2022 | -5.00% |
| Mar 31, 2022 | -650.00% |
| Dec 31, 2021 | -22.50% |
| Sep 30, 2021 | 2.70% |
| Jun 30, 2021 | -21.21% |
| Mar 31, 2021 | 116.67% |
| Dec 31, 2020 | 18.37% |
| Sep 30, 2020 | 5.13% |
| Jun 30, 2020 | -200.00% |
| Mar 31, 2020 | -63.64% |
| Dec 31, 2019 | -40.00% |
| Sep 30, 2019 | -105.26% |
| Jun 30, 2019 | 50.00% |
| Mar 31, 2019 | -37.50% |
| Dec 31, 2018 | -105.88% |
| Sep 30, 2018 | -190.48% |
| Jun 30, 2018 | -83.33% |
| Mar 31, 2018 | -60.00% |
| Dec 31, 2017 | -112.50% |
| Sep 30, 2017 | 362.50% |
| Jun 30, 2017 | -100.00% |
| Mar 31, 2017 | -42.86% |
| Dec 31, 2016 | 65.22% |
| Sep 30, 2016 | 38.46% |
| Jun 30, 2016 | -20.00% |
| Mar 31, 2016 | 22.22% |